No insider purchase over the last 90 days. The latest was filed 24 Apr 2026.
This page follows insider dealings at ZAG as filed with ASX, a company from the Chemicals sector. Between 18 October 2025 and 18 October 2026, 3 insiders published 5 filings.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €54k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 senior executive. One trade stands out by size: a purchase of €54k from Hui (Annie) Guo, disclosed on 24 April 2026, or 0.23% of market capitalisation.
Across the 2,525 companies tracked on its exchange, the median is 3 filings; at 5 filings, this issuer sits above that mark. Our records for ZAG go back to 2026, with 1 purchase and no sales on the open market in total.
The last insider purchase was made public on 24 April 2026, 176 days ago.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2024 · cache
5 of 5 declarations
ZAG is a company operating in the chemicals and materials sector. It is listed on the XASX.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 4 filings published between 19 August and 14 October 2026: no open-market purchase or sale filed by an insider. 4 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 15 October 2026 (UTC)